On April 19, Oklahoma Governor Kevin Stitt signed HB 2678 into law. The new law prohibits the use of copay accumulator programs as an unfair claims settlement practice. Recently increasing in prevalence, copay accumulator programs prevent the value of a drug manufacturer’s financial assistance from counting toward a patient’s deductible and maximum out-of-pocket limit, which can have a significant financial impact on patients. Copay accumulator programs can result in patients rationing their medication or abandoning treatment altogether. As such, patients may experience disease progression, relapse, and other adverse events. The new law, effective November 1, 2021, ensures that any third-party payment on behalf of the patient is counted towards the out-of-pocket maximum, deductible, copay, or other cost-sharing requirement. Read the new law here.
Last Updated on April 21, 2021 by Aimed Alliance
